LayerLogic develops a portable biosensor utilizing graphene field effect transistors to detect and quantify bacteria, viruses, fungi, and molecules with sensitivity comparable to PCR tests. This technology provides rapid digital results within minutes, addressing the need for quick and reliable substance detection in various applications.
Funding
$41.2K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Current methods for detecting and quantifying biological substances like bacteria, viruses, and fungi often require laboratory analysis, leading to delays in obtaining results. Traditional diagnostic techniques can be time-consuming and may not be suitable for rapid, point-of-care applications.
Solution
LayerLogic is developing a portable biosensor that utilizes graphene field-effect transistors to enable rapid detection and quantification of various biological substances. The technology offers sensitivity comparable to PCR tests, delivering digital results within minutes. This allows for quick and reliable substance detection in diverse settings, eliminating the need for extensive laboratory infrastructure. The biosensor is designed to be versatile, capable of detecting bacteria, viruses, fungi, and molecules with high precision.
Target Audience
The primary target audience includes researchers, healthcare providers, and industries requiring rapid and accurate detection of biological substances.
Features
- Graphene field-effect transistor technology for highly sensitive detection
- Portable design for point-of-care testing and on-site analysis
- Rapid digital results available within minutes
- Broad detection capability for bacteria, viruses, fungi, and molecules
- Sensitivity comparable to PCR tests